971 related articles for article (PubMed ID: 19690224)
1. Regional citrate anticoagulation for PrismaFlex continuous renal replacement therapy.
Burry LD; Tung DD; Hallett D; Bailie T; Carvalhana V; Lee D; Ramganesh S; Richardson R; Mehta S; Lapinsky SE
Ann Pharmacother; 2009 Sep; 43(9):1419-25. PubMed ID: 19690224
[TBL] [Abstract][Full Text] [Related]
2. Is regional citrate superior to systemic heparin anticoagulation for continuous renal replacement therapy? A prospective observational study in an adult regional critical care system.
Bagshaw SM; Laupland KB; Boiteau PJ; Godinez-Luna T
J Crit Care; 2005 Jun; 20(2):155-61. PubMed ID: 16139156
[TBL] [Abstract][Full Text] [Related]
3. Continuous renal replacement therapies: anticoagulation in the critically ill at high risk of bleeding.
Morabito S; Guzzo I; Solazzo A; Muzi L; Luciani R; Pierucci A
J Nephrol; 2003; 16(4):566-71. PubMed ID: 14696760
[TBL] [Abstract][Full Text] [Related]
4. Regional citrate anticoagulation for high volume continuous venovenous hemodialysis in surgical patients with high bleeding risk.
Kalb R; Kram R; Morgera S; Slowinski T; Kindgen-Milles D
Ther Apher Dial; 2013 Apr; 17(2):202-12. PubMed ID: 23551677
[TBL] [Abstract][Full Text] [Related]
5. Regional citrate anticoagulation in predilution continuous venovenous hemofiltration using prismocitrate 10/2 solution.
Shum HP; Chan KC; Yan WW
Ther Apher Dial; 2012 Feb; 16(1):81-6. PubMed ID: 22248200
[TBL] [Abstract][Full Text] [Related]
6. Citrate clearance in children receiving continuous venovenous renal replacement therapy.
Chadha V; Garg U; Warady BA; Alon US
Pediatr Nephrol; 2002 Oct; 17(10):819-24. PubMed ID: 12376810
[TBL] [Abstract][Full Text] [Related]
7. Citrate anticoagulation in continuous venovenous hemodiafiltration: a metabolic challenge.
Gabutti L; Marone C; Colucci G; Duchini F; Schönholzer C
Intensive Care Med; 2002 Oct; 28(10):1419-25. PubMed ID: 12373466
[TBL] [Abstract][Full Text] [Related]
8. Advances in continuous renal replacement therapy: citrate anticoagulation update.
Tolwani A; Wille KM
Blood Purif; 2012; 34(2):88-93. PubMed ID: 23095407
[TBL] [Abstract][Full Text] [Related]
9. Citrate anticoagulation for continuous renal replacement therapy in the critically ill.
Oudemans-van Straaten HM
Blood Purif; 2010; 29(2):191-6. PubMed ID: 20093826
[TBL] [Abstract][Full Text] [Related]
10. The use of regional citrate anticoagulation for continuous venovenous hemodiafiltration in acute kidney injury.
Durão MS; Monte JC; Batista MC; Oliveira M; Iizuka IJ; Santos BF; Pereira VG; Cendoroglo M; Santos OF
Crit Care Med; 2008 Nov; 36(11):3024-9. PubMed ID: 18824904
[TBL] [Abstract][Full Text] [Related]
11. [Safety and efficacy of regional citrate anticoagulation in continuous renal replacement therapy in the presence of acute kidney injury after hepatectomy].
Zhang C; Lin T; Zhang J; Liang H; Di Y; Li N; Gao J; Wang W; Liu S; Wang Z; Jiang H; Liu C
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2018 Aug; 30(8):777-782. PubMed ID: 30220281
[TBL] [Abstract][Full Text] [Related]
12. [Continuous renal replacement therapies (CRRT) will remain the most widely adopted dialysis modality in the critically ill].
Morabito S; Pistolesi V; Cibelli L; Pierucci A
G Ital Nefrol; 2009; 26(1):13-21. PubMed ID: 19255959
[TBL] [Abstract][Full Text] [Related]
13. Regional citrate anticoagulation in continuous venovenous hemofiltration in critically ill patients with a high risk of bleeding.
Palsson R; Niles JL
Kidney Int; 1999 May; 55(5):1991-7. PubMed ID: 10231464
[TBL] [Abstract][Full Text] [Related]
14. Anticoagulation for continuous renal replacement therapy.
Tolwani AJ; Wille KM
Semin Dial; 2009; 22(2):141-5. PubMed ID: 19426417
[TBL] [Abstract][Full Text] [Related]
15. Continuous venovenous hemofiltration with citrate-based replacement fluid: efficacy, safety, and impact on nutrition.
Bihorac A; Ross EA
Am J Kidney Dis; 2005 Nov; 46(5):908-18. PubMed ID: 16253732
[TBL] [Abstract][Full Text] [Related]
16. A regional citrate anticoagulation protocol for pre-dilutional CVVHDf: the 'Modified Alabama Protocol'.
Davies H; Morgan D; Leslie G
Aust Crit Care; 2008 Aug; 21(3):154-65. PubMed ID: 18635373
[TBL] [Abstract][Full Text] [Related]
17. Regional citrate anticoagulation in critically ill patients with liver and kidney failure.
Balogun RA; Turgut F; Caldwell S; Abdel-Rahman EM
J Nephrol; 2012; 25(1):113-9. PubMed ID: 21607918
[TBL] [Abstract][Full Text] [Related]
18. Exclusive use of acid citrate dextrose for anticoagulation during extracorporeal photopheresis in patients with contraindications to heparin: an effective protocol.
Nedelcu E; Ziman A; Fernando LP; Cook K; Bumerts P; Schiller G
J Clin Apher; 2008; 23(2):66-73. PubMed ID: 18286495
[TBL] [Abstract][Full Text] [Related]
19. Acute renal failure in critically ill surgical patients: persistent lethality despite new modes of renal replacement therapy.
Eachempati SR; Wang JC; Hydo LJ; Shou J; Barie PS
J Trauma; 2007 Nov; 63(5):987-93. PubMed ID: 17993940
[TBL] [Abstract][Full Text] [Related]
20. Safety and efficacy of regional citrate anticoagulation for continuous renal replacement therapy in liver failure patients: a systematic review and meta-analysis.
Zhang W; Bai M; Yu Y; Li L; Zhao L; Sun S; Chen X
Crit Care; 2019 Jan; 23(1):22. PubMed ID: 30678706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
